Cargando…
Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-CoV-2 and Variants of Concern
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Singapore
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609258/ https://www.ncbi.nlm.nih.gov/pubmed/34815511 http://dx.doi.org/10.1038/s41422-021-00590-x |
| _version_ | 1784602892412387328 |
|---|---|
| author | Ai, Jingwen Zhang, Haocheng Zhang, Qiran Zhang, Yi Lin, Ke Fu, Zhangfan Song, Jieyu Zhao, Yuanhan Fan, Mingxiang Wang, Hongyu Qiu, Chao Zhou, Yang Zhang, Wenhong |
| author_facet | Ai, Jingwen Zhang, Haocheng Zhang, Qiran Zhang, Yi Lin, Ke Fu, Zhangfan Song, Jieyu Zhao, Yuanhan Fan, Mingxiang Wang, Hongyu Qiu, Chao Zhou, Yang Zhang, Wenhong |
| author_sort | Ai, Jingwen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8609258 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Singapore |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86092582021-11-23 Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-CoV-2 and Variants of Concern Ai, Jingwen Zhang, Haocheng Zhang, Qiran Zhang, Yi Lin, Ke Fu, Zhangfan Song, Jieyu Zhao, Yuanhan Fan, Mingxiang Wang, Hongyu Qiu, Chao Zhou, Yang Zhang, Wenhong Cell Res Letter to the Editor Springer Singapore 2021-11-23 2022-01 /pmc/articles/PMC8609258/ /pubmed/34815511 http://dx.doi.org/10.1038/s41422-021-00590-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter to the Editor Ai, Jingwen Zhang, Haocheng Zhang, Qiran Zhang, Yi Lin, Ke Fu, Zhangfan Song, Jieyu Zhao, Yuanhan Fan, Mingxiang Wang, Hongyu Qiu, Chao Zhou, Yang Zhang, Wenhong Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-CoV-2 and Variants of Concern |
| title | Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-CoV-2 and Variants of Concern |
| title_full | Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-CoV-2 and Variants of Concern |
| title_fullStr | Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-CoV-2 and Variants of Concern |
| title_full_unstemmed | Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-CoV-2 and Variants of Concern |
| title_short | Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-CoV-2 and Variants of Concern |
| title_sort | recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-rbd responses and neutralizing titers against sars-cov-2 and variants of concern |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609258/ https://www.ncbi.nlm.nih.gov/pubmed/34815511 http://dx.doi.org/10.1038/s41422-021-00590-x |
| work_keys_str_mv | AT aijingwen recombinantproteinsubunitvaccineboosterfollowingtwodoseinactivatedvaccinesdramaticallyenhancedantirbdresponsesandneutralizingtitersagainstsarscov2andvariantsofconcern AT zhanghaocheng recombinantproteinsubunitvaccineboosterfollowingtwodoseinactivatedvaccinesdramaticallyenhancedantirbdresponsesandneutralizingtitersagainstsarscov2andvariantsofconcern AT zhangqiran recombinantproteinsubunitvaccineboosterfollowingtwodoseinactivatedvaccinesdramaticallyenhancedantirbdresponsesandneutralizingtitersagainstsarscov2andvariantsofconcern AT zhangyi recombinantproteinsubunitvaccineboosterfollowingtwodoseinactivatedvaccinesdramaticallyenhancedantirbdresponsesandneutralizingtitersagainstsarscov2andvariantsofconcern AT linke recombinantproteinsubunitvaccineboosterfollowingtwodoseinactivatedvaccinesdramaticallyenhancedantirbdresponsesandneutralizingtitersagainstsarscov2andvariantsofconcern AT fuzhangfan recombinantproteinsubunitvaccineboosterfollowingtwodoseinactivatedvaccinesdramaticallyenhancedantirbdresponsesandneutralizingtitersagainstsarscov2andvariantsofconcern AT songjieyu recombinantproteinsubunitvaccineboosterfollowingtwodoseinactivatedvaccinesdramaticallyenhancedantirbdresponsesandneutralizingtitersagainstsarscov2andvariantsofconcern AT zhaoyuanhan recombinantproteinsubunitvaccineboosterfollowingtwodoseinactivatedvaccinesdramaticallyenhancedantirbdresponsesandneutralizingtitersagainstsarscov2andvariantsofconcern AT fanmingxiang recombinantproteinsubunitvaccineboosterfollowingtwodoseinactivatedvaccinesdramaticallyenhancedantirbdresponsesandneutralizingtitersagainstsarscov2andvariantsofconcern AT wanghongyu recombinantproteinsubunitvaccineboosterfollowingtwodoseinactivatedvaccinesdramaticallyenhancedantirbdresponsesandneutralizingtitersagainstsarscov2andvariantsofconcern AT qiuchao recombinantproteinsubunitvaccineboosterfollowingtwodoseinactivatedvaccinesdramaticallyenhancedantirbdresponsesandneutralizingtitersagainstsarscov2andvariantsofconcern AT zhouyang recombinantproteinsubunitvaccineboosterfollowingtwodoseinactivatedvaccinesdramaticallyenhancedantirbdresponsesandneutralizingtitersagainstsarscov2andvariantsofconcern AT zhangwenhong recombinantproteinsubunitvaccineboosterfollowingtwodoseinactivatedvaccinesdramaticallyenhancedantirbdresponsesandneutralizingtitersagainstsarscov2andvariantsofconcern |